SK282183B6 - Farmaceutický prostriedok - Google Patents

Farmaceutický prostriedok Download PDF

Info

Publication number
SK282183B6
SK282183B6 SK236-97A SK23697A SK282183B6 SK 282183 B6 SK282183 B6 SK 282183B6 SK 23697 A SK23697 A SK 23697A SK 282183 B6 SK282183 B6 SK 282183B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
composition according
ibuprofen
mixtures
cellulose
Prior art date
Application number
SK236-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK23697A3 (en
Inventor
Brian Holmes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417041A external-priority patent/GB9417041D0/en
Priority claimed from GB9419921A external-priority patent/GB9419921D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK23697A3 publication Critical patent/SK23697A3/sk
Publication of SK282183B6 publication Critical patent/SK282183B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK236-97A 1994-08-23 1995-08-16 Farmaceutický prostriedok SK282183B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417041A GB9417041D0 (en) 1994-08-23 1994-08-23 Improved formulations
GB9419921A GB9419921D0 (en) 1994-10-04 1994-10-04 Improved formulations
PCT/GB1995/001947 WO1996005834A1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Publications (2)

Publication Number Publication Date
SK23697A3 SK23697A3 (en) 1997-08-06
SK282183B6 true SK282183B6 (sk) 2001-11-06

Family

ID=26305507

Family Applications (1)

Application Number Title Priority Date Filing Date
SK236-97A SK282183B6 (sk) 1994-08-23 1995-08-16 Farmaceutický prostriedok

Country Status (24)

Country Link
EP (1) EP0777477B1 (ru)
JP (1) JP3874793B2 (ru)
KR (1) KR100397082B1 (ru)
CN (1) CN1083265C (ru)
AT (1) ATE227574T1 (ru)
AU (1) AU699224B2 (ru)
BG (1) BG63329B1 (ru)
BR (1) BR9508760A (ru)
CA (1) CA2156768A1 (ru)
CZ (1) CZ287558B6 (ru)
DE (1) DE69528838T2 (ru)
DK (1) DK0777477T3 (ru)
ES (1) ES2187566T3 (ru)
HU (1) HU227759B1 (ru)
MX (1) MX9701390A (ru)
NO (1) NO322200B1 (ru)
NZ (1) NZ291223A (ru)
PL (1) PL181215B1 (ru)
PT (1) PT777477E (ru)
RU (1) RU2140782C1 (ru)
SK (1) SK282183B6 (ru)
TW (1) TW493984B (ru)
UA (1) UA42781C2 (ru)
WO (1) WO1996005834A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
US8034801B2 (en) 2006-07-12 2011-10-11 Aska Pharmaceutical Co., Ltd. Analgesic agent
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
AR062321A1 (es) 2006-08-25 2008-10-29 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo
KR20090065513A (ko) * 2006-10-05 2009-06-22 코와 가부시키가이샤 이부프로펜 및 트라넥삼산을 함유하는 고형 제제
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
US8491930B2 (en) 2008-04-23 2013-07-23 Farmasierra Manufacturing, S.L. Pharmaceutical formulation containing ibuprofen and codeine
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
MX2017002701A (es) 2014-08-28 2017-08-28 Sanofi Aventis Deutschland Comprimido recubierto con pelicula para el tratamiento del dolor agudo.
CN105395508B (zh) * 2015-12-14 2018-06-29 西南药业股份有限公司 一种洛芬待因复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
NO970782D0 (no) 1997-02-20
MX9701390A (es) 1998-06-30
CZ54697A3 (en) 1997-12-17
EP0777477B1 (en) 2002-11-13
AU3228995A (en) 1996-03-14
EP0777477A1 (en) 1997-06-11
HUT77385A (hu) 1998-04-28
DK0777477T3 (da) 2003-03-17
JPH10504557A (ja) 1998-05-06
DE69528838D1 (de) 2002-12-19
NO322200B1 (no) 2006-08-28
UA42781C2 (ru) 2001-11-15
BG63329B1 (bg) 2001-10-31
RU2140782C1 (ru) 1999-11-10
HU227759B1 (en) 2012-02-28
WO1996005834A1 (en) 1996-02-29
BR9508760A (pt) 1998-01-13
NO970782L (no) 1997-02-20
CN1083265C (zh) 2002-04-24
PT777477E (pt) 2003-03-31
DE69528838T2 (de) 2003-07-10
KR100397082B1 (ko) 2004-02-11
SK23697A3 (en) 1997-08-06
TW493984B (en) 2002-07-11
BG101252A (en) 1998-02-27
PL181215B1 (pl) 2001-06-29
ATE227574T1 (de) 2002-11-15
JP3874793B2 (ja) 2007-01-31
KR970705389A (ko) 1997-10-09
AU699224B2 (en) 1998-11-26
NZ291223A (en) 1998-12-23
PL318807A1 (en) 1997-07-07
CZ287558B6 (en) 2000-12-13
CA2156768A1 (en) 1996-02-24
CN1159754A (zh) 1997-09-17
ES2187566T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
SK282183B6 (sk) Farmaceutický prostriedok
AU602375B2 (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain h1 and h2 receptor blockers
JP4832045B2 (ja) メキタジン、イブプロフェン及びトラネキサム酸含有医薬組成物
US4839176A (en) Therapeutic agents
HRP20010332A2 (en) Pharmaceutical moxifloxacin preparation
CA1300509C (en) Pharmaceutical compositions for relief of dysmenorrhea and/orpremenstrual syndrome and process
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
JPH05246845A (ja) イブプロフェン含有解熱鎮痛剤
JPH0141608B2 (ru)
JP6160263B2 (ja) ロキソプロフェン含有医薬組成物
US4083950A (en) Stable acetylsalicylic acid and phenylpropanolamine salt composition
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
JP6106359B2 (ja) ロキソプロフェンナトリウムとビタミンb1を含有する固形製剤
JP2009007295A (ja) イブプロフェンの昇華が抑制された固形製剤
JP2007031281A (ja) イブプロフェン含有フィルムコーティング錠剤
WO2019121857A1 (en) Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
JP2015134839A (ja) ロキソプロフェン含有医薬組成物
JP2022031251A (ja) 医薬組成物
CA2191855C (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
BRPI0707736A2 (pt) formulaÇÕes de imidazolilalquil-piridinas de dosagem estÁvel
JP2010037224A (ja) エテンザミドの昇華が抑制された固形製剤

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20150816